The overall technological goal is to upgrade our unique single-particle microbeam facility to improve the spatial resolution from +/- 3.5 mum, and to allow the use of more densely-ionizing radiations (i.e. heavier ion beams, with stopping powers from 15 to 4,500 keV/mum), compared with our current beams of H and He ins (stopping power range 15 to 200 keV/mum). The main specific technological goals are: 1. replacing the current physical collimator system with electrostatic lenses, that we will design and build. 2. replacing the current multiple-magnet beam transport system with a single magnet; 3. designing and building an on-line beam-shape verification system; 4. improving our cellular/sub-cellular optical identification system to a level commensurate with the +/- 0.3 mum resolution of the microbeam; 5. replacing the current ion source with a laser ion source that we shall design and build, allowing high charge-state ion bemas of essentially any element to be accelerated; 6. design/optimization/fabrication of the ion transport system to function independently of the accelerated ion type; 7. design/fabrication of a new differentially-pumped gaseous ion detector, within the beam optics system. In collaboration with investigators from outside and within Columbia University, 28 collaborative- and service-outgrowths of funded NIH research, many at the current RARAF facility. 7 of these projects originate from Columbia University, and 21 from other institutions. Training and information dissemination will continue to be important components of this resource. Training will continue to play an important role at the undergraduate, graduate, post doctoral, and senior scientist levels. Information dissemination will continue through organizing bi- annual international microbeam workshops, talks at national and international meetings, written and web-based user information, and peer- reviewed publications.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Biotechnology Resource Grants (P41)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-RAD (01))
Program Officer
Sheeley, Douglas
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
Schools of Medicine
New York
United States
Zip Code
Chai, Y; Calaf, G M; Zhou, H et al. (2013) Radiation induced COX-2 expression and mutagenesis at non-targeted lung tissues of gpt delta transgenic mice. Br J Cancer 108:91-8
Chai, Y; Lam, R K K; Calaf, G M et al. (2013) Radiation-induced non-targeted response in vivo: role of the TGFýý-TGFBR1-COX-2 signalling pathway. Br J Cancer 108:1106-12
Hu, Burong; Grabham, Peter; Nie, Jing et al. (2012) Intrachromosomal changes and genomic instability in site-specific microbeam-irradiated and bystander human-hamster hybrid cells. Radiat Res 177:25-34
Hei, Tom K; Zhao, Yongliang; Zhou, Hongning et al. (2011) Mechanism of radiation carcinogenesis: role of the TGFBI gene and the inflammatory signaling cascade. Adv Exp Med Biol 720:163-70
Hei, Tom K; Ballas, Leslie K; Brenner, David J et al. (2009) Advances in radiobiological studies using a microbeam. J Radiat Res 50 Suppl A:A7-A12
Chai, Yunfei; Hei, Tom K (2008) Radiation Induced Bystander Effect in vivo. Acta Med Nagasaki 53:S65-S69
Brenner, David J (2008) The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18:234-9
Hei, Tom K; Zhou, Hongning; Ivanov, Vladimir N et al. (2008) Mechanism of radiation-induced bystander effects: a unifying model. J Pharm Pharmacol 60:943-50
Ponnaiya, Brian; Jenkins-Baker, Gloria; Randers-Pherson, Gerhard et al. (2007) Quantifying a bystander response following microbeam irradiation using single-cell RT-PCR analyses. Exp Hematol 35:64-8
Hei, Tom K (2006) Cyclooxygenase-2 as a signaling molecule in radiation-induced bystander effect. Mol Carcinog 45:455-60

Showing the most recent 10 out of 64 publications